Demodex blepharitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who met the diagnosis of demodex blepharitis; 2. Light dry eye or light to moderate MGD; 3. Aged 18 to 50 years; 4. Symptom score: SPEED >= 6; 5. Schirmer test>=5 mm/min; 6. Changes in Meibomian glandular secretion; 7. Tear film breakup time <= 5s; 8. Subjects must sign informed consent, be willing to cooperate with treatment and follow-up, and voluntarily participate in this study.
Exclusion criteria
Exclusion criteria: 1. Women during lactation or pregnancy; 2. Acute ocular inflammation or infection; 3. Eyelid margin has obvious scar or keratinization; 4. Received eye surgery or eyelid surgery within 6 months before enrollment; 5. Nerve palsy occurred in the treatment area within 6 months before enrollment; 6. Systemic disease including diabetes, autoimmune and infectious diseases; 7. Lacrimal duct embolization; 8. Precancerous skin cancer or pigmentation in the treatment area; 9. Had LASIK surgery within 12 months before enrollment; 10. Follow up observation less than 2 times after treatment; 11. The follow-up time exceeded the scheduled time by more than 1w; 12. Misdiagnosis found after the beginning of treatment (those meeting the exclusion criteria); 13. Receive ocular or systemic surgery during the study period; 14. New exclusion criteria occur or no data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of Demodex; | — |
Countries
China
Contacts
Hankou Aier Eye Hospital